Studies from Stanford University Update Current Data on Non-Small Cell Lung Cancer (Molecular Characteristics and Pretreatment Neutrophil-to-lymphocyte Ratio As Predictors of Durable Clinical Benefit From Immune Checkpoint Inhibition In ...)

Press/Media

PeriodSep 27 2024

Media coverage

1

Media coverage

  • TitleStudies from Stanford University Update Current Data on Non-Small Cell Lung Cancer (Molecular Characteristics and Pretreatment Neutrophil-to-lymphocyte Ratio As Predictors of Durable Clinical Benefit From Immune Checkpoint Inhibition In ...)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date09/27/24
    PersonsSukhmani Kaur Padda